We therefore also examined our data for differential expression of CD cell-surface markers and found that CD19, CD47, CD52 and CD79A were significantly downregulated while only CD164 was significantly upregulated in ME/CFS lymphoblasts (Table S3). This evidence concerns the gene CD164 and myalgic encephalomeyelitis/chronic fatigue syndrome.